<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Cerivastatin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Cerivastatin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Cerivastatin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Cerivastatin</b> (INN,<span class="mw-ref" id="cite_ref-INN_1-0"><a href="#cite_note-INN-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> brand names: <b>Baycol</b>, <b>Lipobay</b>) is a synthetic member of the class of statins used to lower <a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">cholesterol</a> and prevent cardiovascular disease. It was marketed by the pharmaceutical company Bayer A.G. in the late 1990s, competing with Pfizer's highly successful <a href="Atorvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Atorvastatin" title="Atorvastatin">atorvastatin</a> (Lipitor). Cerivastatin was voluntarily withdrawn from the market worldwide in 2001, due to reports of fatal rhabdomyolysis.</p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Cerivastatin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Cerivastatin.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Cerivastatin.svg.png" data-file-width="512" data-file-height="288" data-file-type="drawing" height="155" width="275"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>C10AA06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=C10AA06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=C10AA06'" tppabs="https://www.whocc.no/atc_ddd_index/?code=C10AA06" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>Withdrawn</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>2–3 hours</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(3<i>R</i>,5<i>S</i>,6<i>E</i>)-7-[4-(4-Fluorophenyl)-5-(methoxymethyl)-2,6-bis(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=145599-86-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=145599-86-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=145599-86-6" class="external text external">145599-86-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/446156  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/446156'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/446156" class="external text external">446156</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2950  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2950'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2950" class="external text external">2950</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00439'" tppabs="https://www.drugbank.ca/drugs/DB00439" class="external text external">DB00439</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.393588.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.393588.html'" tppabs="http://www.chemspider.com/Chemical-Structure.393588.html" class="external text external">393588</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=AM91H2KS67  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=AM91H2KS67'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=AM91H2KS67" class="external text external">AM91H2KS67</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D07661  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D07661'" tppabs="https://www.kegg.jp/entry/D07661" class="external text external">D07661</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3558  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3558'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3558" class="external text external">CHEBI:3558</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1477  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1477'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1477" class="external text external">ChEMBL1477</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID9022786  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID9022786'" tppabs="https://comptox.epa.gov/dashboard/DTXSID9022786" class="external text external">DTXSID9022786</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>26</sub><span>H</span><sub>34</sub><span>F</span><span>N</span><span>O</span><sub>5</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">459.558</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29%2FC%3DC%2Fc1c%28nc%28c%28c1c2ccc%28F%29cc2%29COC%29C%28C%29C%29C%28C%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29%2FC%3DC%2Fc1c%28nc%28c%28c1c2ccc%28F%29cc2%29COC%29C%28C%29C%29C%28C%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%5BC%40H%5D%28O%29C%5BC%40H%5D%28O%29%2FC%3DC%2Fc1c%28nc%28c%28c1c2ccc%28F%29cc2%29COC%29C%28C%29C%29C%28C%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(nc(c(c1c2ccc(F)cc2)COC)C(C)C)C(C)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C26H34FNO5/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32)/b11-10+/t19-,20-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:SEERZIQQUAZTOL-ANMDKAQQSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460025724&page2=Cerivastatin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460025724&page2=Cerivastatin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=460025724&page2=Cerivastatin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>During postmarketing surveillance, 52 deaths were reported in patients using cerivastatin, mainly from rhabdomyolysis and its resultant kidney failure.<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Risks were higher in patients using fibrates, mainly <a href="Gemfibrozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemfibrozil" title="Gemfibrozil">gemfibrozil</a> (Lopid), and in patients using the highest (0.8<span>&nbsp;</span>mg/day) dose of cerivastatin. Bayer A.G. added a contraindication for the concomitant use of cerivastatin and gemfibrozil to the package 18 months after the drug interaction was found.<span class="mw-ref" id="cite_ref-pmid15572720_3-0"><a href="#cite_note-pmid15572720-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The frequency of deadly cases of rhabdomyolysis with cerivastatin was 16 to 80 times higher than with other statins.<span class="mw-ref" id="cite_ref-pmid12879633_4-0"><a href="#cite_note-pmid12879633-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Another 385 nonfatal cases of rhabdomyolysis were reported. This put the risk of this (rare) complication at 5-10 times that of the other statins. Cerivastatin also induced myopathy in a dose-dependent manner when administered as monotherapy, but that was revealed only after Bayer was sued and unpublished company documents were opened.<span class="mw-ref" id="cite_ref-pmid16541751_5-0"><a href="#cite_note-pmid16541751-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Structure_and_reactivity">Structure and reactivity</h2></summary>
    
<p>Cerivastatin consists of a fluorophenyl linked to a pyridine. The pyridine has two propanyl groups, one methoxy group and dihydroxyheptanoic acid. The dihydroxyheptanoic acid group is the functional part of the molecule. This part will bind to the HMG-CoA reductase making it unavailable for HMG-CoA.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Cerivastatin is a pure synthetic drug, produced to create a more potent inhibitor of HMG-CoA reductase. Cerivastatin was the most potent inhibitor with an inhibitory constant of 0.5<span>&nbsp;</span>µg/L, which made it already effective at a low dose. It is taken up orally as tablets, where it is combined with sodium salt. The IUPAC name is then (+)-(3R,5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethylpyridin-3-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Cerivastatin sodium (C22H33FNO3Na) is administered orally via a tablet. The molecular weight is 481.5 g/mol.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is odorless and it is soluble in water, methanol and ethanol. Under acidic circumstances, it undergoes cyclization to form pyridinolactone.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>Five main classes of agents can be used to treat hyperlipidemia, a condition that comes with high cholesterol levels. Those are bile acid sequestrants, nicotinic acid, fibric acid derivatives, <a href="Probucol.htm" tppabs="https://ptable.com/wiki/compounds/A/Probucol" title="Probucol">probucol</a> and HMG-CoA-reductase inhibitors. Cerivastatin mainly acts by competitively inhibiting HMG-CoA-reductase, which is the rate-limiting enzyme step in cholesterol biosynthesis.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It occurs during the mevalonate pathway in the liver, where hydroxylmethylglutaryl is converted to mevalonate.
Cerivastatin is a synthetic and enantiomerically pure inhibitor of the reductase, meaning it can fit into the enzyme’s active site, and therefore compete with the substrate HMG-CoA, which is the native substrate for the reductase.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Due to the competition, the rate of mevalonate production by the enzyme is reduced. This also means that the rates subsequent biosynthesis is reduced, since less starting material is available.  Eventually, this will lead to lower cholesterol levels.</p>

<p>The location of cholesterol biosynthesis and inhibition of HMG-CoA is of significance, since most circulating cholesterol originates from internal production, rather than the diet. If the liver cannot produce more cholesterol, the cholesterol levels in the blood will decrease. Also, HMG-CoA-reductase inhibitors cause secondary up-regulation of hepatic LDL receptors, with increased LDL-cholesterol clearance and reduction of both total and LDL cholesterol in the serum.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Metabolism">Metabolism</h2></summary>
    
<p>Cerivastatin is metabolized via the hepatic pathway.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> <i>In vitro</i> studies with human liver cells showed that two metabolic pathways are equally important; demethylation of the benzylic methyl ether and hydroxylation at one methyl group of the 6-isopropyl substituent.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Demethylation is catalysed by the enzymes CYP2C8 and CYP3A4, which generates a metabolite that is known as M-1 in the cerivastatin metabolite pathway. Hydroxylation is catalysed by CYP2C8, which generates the major active metabolite, M-23.<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> M-1 and M-23 are, like cerivastatin, pharmacologically active, with comparable potencies. Combination of the latter leads to another minor metabolite, that is not detectable in plasma, which is also known as M-24. Following a 0.8<span>&nbsp;</span>mg dose of cerivastatin, the mean steady state Cmax values for cerivastatin, M-1 and M-23 were 12.7, 0.55 and 1.4 μg/L, respectively. Hence, it can be concluded that the cholesterol-lowering effect is mostly due to the cerivastatin itself.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Efficacy,_toxicity_and_side_effects">Efficacy, toxicity and side effects</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Efficacy_and_toxicity">Efficacy and toxicity</h3></summary>
    
<p>The inhibitory activity of cerivastatin was compared to that of other statins, specifically lovastatin, simvastatin and pravastatin. This comparison was made by determining the IC50 values of each compound. These values were 77 nM, 66 nM and 176 nM for these statins, respectively, while the value for cerivastatin was found to be 1.1 nM.
Using Dixon plots, the inhibitory constant of cerivastatin was found to be 1.3 x 10-9 M, which is over 100 times lower than the inhibitory constant of <a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">lovastatin</a>, known to be 150 x 10-9 M.
To compare cerivastatin activity to that of other statins, its IC25 value was also determined for various types of human smooth muscle cells: cells from the left internal mammary artery (HSMC), cornea fibroblasts (HCF), myoblasts from striated muscle (HM) and umbilical vein endothelial cells (HUVEC). The activity in these groups of muscle cells was compared to the activity of the statins listed above, as well as atorvastatin and <a href="Fluvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvastatin" title="Fluvastatin">fluvastatin</a>.</p>

<p>The pharmacological results from cerivastatin show that it is the most active HMG-CoA-reductase inhibitor among reported statins. Due to its high enzyme affinity, it would seem to offer ultra-low dose therapy in the microgram range. However, due to its relatively severe adverse effects in comparison to other statins, its market use was discontinued.</p>

<p>The strengths of the available cerivastatin medicine ranged from 0.2 - 0.8<span>&nbsp;</span>mg, resulting in an actual dose of 1.9 - 13.1 μg/kg body weight for which rhabdomyolysis has been reported.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Although the mechanism of the cerivastatin induced myopathy is not exactly known,<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> the risk increases with statin dose.<span class="mw-ref" id="cite_ref-pmid15572720_3-1"><a href="#cite_note-pmid15572720-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> This risk also appears to increase among patients who received <a href="Gemfibrozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemfibrozil" title="Gemfibrozil">gemfibrozil</a><span class="mw-ref" id="cite_ref-pmid15572720_3-2"><a href="#cite_note-pmid15572720-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> or lovastatin<span class="mw-ref" id="cite_ref-Staffa_2002_22-0"><a href="#cite_note-Staffa_2002-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> concomitantly, and there is a known interaction between these drugs and cerivastatin. There are 31 cerivastatin-related deaths reported in the USA and a further 21 deaths worldwide. There were also 385 cases of non-fatal rhabdomyolysis reported among the estimated 700.000 users in the USA.<span class="mw-ref" id="cite_ref-pmid15572720_3-3"><a href="#cite_note-pmid15572720-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In 12 of the 31 reported deaths of cerivastatin-related rhabdomyolysis in the US the cerivastatin-gemfibrozil interaction was implicated, while in 7 of the 31 fatal cases in the US, cerivastatin was combined with lovastatin.<span class="mw-ref" id="cite_ref-pmid15572720_3-4"><a href="#cite_note-pmid15572720-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Staffa_2002_22-1"><a href="#cite_note-Staffa_2002-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> The reporting rate of fatal rhabdomyolysis in association with cerivastatin monotherapy is 1.9 per million prescriptions, which is 10-50 times as high as for other statins.<span class="mw-ref" id="cite_ref-Staffa_2002_22-2"><a href="#cite_note-Staffa_2002-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Adverse_effects">Adverse effects</h3></summary>
    
<p>Cerivastatin was generally found to be well tolerated, side effects being rare. Minor side effects include diarrhea, fatigue, gas, heartburn, nasal congestion and headache. Patients with alcoholic or other liver diseases were advised to use cerivastatin with caution.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-INN-1"> <span id="mw-reference-text-cite_note-INN-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.who.int/medicines/publications/druginformation/innlists/RL36.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/medicines/publications/druginformation/innlists/RL36.pdf'" tppabs="http://www.who.int/medicines/publications/druginformation/innlists/RL36.pdf" class="external text external">"International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 36"</a> <span class="cs1-format">(PDF)</span>. World Health Organization. 1996. p.<span>&nbsp;</span>142<span class="reference-accessdate">. Retrieved <span class="nowrap">29 November</span> 2016</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFFurberg_CD,_Pitt_B2001" class="citation journal cs1">Furberg CD, Pitt B (2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524" class="external text external">"Withdrawal of cerivastatin from the world market"</a>. <i>Curr Control Trials Cardiovasc Med</i>. <b>2</b> (5): 205–207. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2Fcvm-2-5-205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fcvm-2-5-205'" tppabs="https://doi.org/10.1186%2Fcvm-2-5-205" class="external text external">10.1186/cvm-2-5-205</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524" class="external text external">59524</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11806796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11806796'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11806796" class="external text external">11806796</a>.</cite></span></li><li id="cite_note-pmid15572720-3"> <span id="mw-reference-text-cite_note-pmid15572720-3" class="mw-reference-text"><cite id="CITEREFPsatyFurbergRayWeiss2004" class="citation journal cs1">Psaty BM, Furberg CD, Ray WA, Weiss NS (2004). "Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis". <i>JAMA</i>. <b>292</b> (21): 2622–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.292.21.2622  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.292.21.2622'" tppabs="https://doi.org/10.1001%2Fjama.292.21.2622" class="external text external">10.1001/jama.292.21.2622</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15572720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15572720'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15572720" class="external text external">15572720</a>.</cite></span></li><li id="cite_note-pmid12879633-4"> <span id="mw-reference-text-cite_note-pmid12879633-4" class="mw-reference-text"><cite id="CITEREFZeitlingerMüller2003" class="citation journal cs1">Zeitlinger M, Müller M (2003). "[Clinico-pharmacologic explanation models of cerivastatin associated rhabdomyolysis]". <i>Wien Med Wochenschr</i> (in German). <b>153</b> (11–12): 250–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1563-258X.2003.03029.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1563-258X.2003.03029.x'" tppabs="https://doi.org/10.1046%2Fj.1563-258X.2003.03029.x" class="external text external">10.1046/j.1563-258X.2003.03029.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12879633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12879633'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12879633" class="external text external">12879633</a>.</cite></span></li><li id="cite_note-pmid16541751-5"> <span id="mw-reference-text-cite_note-pmid16541751-5" class="mw-reference-text"><cite id="CITEREFSaitoHirata-KoizumiMiyakeHasegawa2005" class="citation journal cs1">Saito M, Hirata-Koizumi M, Miyake S, Hasegawa R (2005). "[Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States]". <i>Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku</i> (in Japanese) (123): 41–5. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16541751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16541751'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16541751" class="external text external">16541751</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00439'" tppabs="https://www.drugbank.ca/drugs/DB00439" class="external text external">"Cerivastatin"</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><a href="javascript:if(confirm('https://link.springer.com/article/10.2165/00003088-200039020-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://link.springer.com/article/10.2165/00003088-200039020-00002#Sec1'" tppabs="https://link.springer.com/article/10.2165/00003088-200039020-00002#Sec1" class="external autonumber external"></a>, 7.Mück W. 2000. Clinical Pharmacokinetics of Cerivastatin <i>Clinical Pharmacokinetics</i> 39(2):99-116</span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00439'" tppabs="https://www.drugbank.ca/drugs/DB00439" class="external text external">"Cerivastatin"</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><a href="javascript:if(confirm('https://link.springer.com/article/10.2165/00003088-200039020-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://link.springer.com/article/10.2165/00003088-200039020-00002#Sec1'" tppabs="https://link.springer.com/article/10.2165/00003088-200039020-00002#Sec1" class="external autonumber external"></a>, 7.Mück W. 2000. Clinical Pharmacokinetics of Cerivastatin <i>Clinical Pharmacokinetics</i> 39(2):99-116</span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFKuhlmannMückBischoffKeutz1998" class="citation journal cs1">Kuhlmann J, Mück W, Bischoff H, Keutz E, Llewellyn M (1998). "Cerivastatin (BAY w 6228): A Novel HMG-CoA Reductase Inhibitor". <i>Cardiovascular Drug Reviews</i>. <b>16</b> (3): 236–263. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1527-3466.1998.tb00357.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1527-3466.1998.tb00357.x'" tppabs="https://doi.org/10.1111%2Fj.1527-3466.1998.tb00357.x" class="external text external">10.1111/j.1527-3466.1998.tb00357.x</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><a href="javascript:if(confirm('http://www.jlr.org/content/33/11/1569.full.pdf+html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jlr.org/content/33/11/1569.full.pdf+html'" tppabs="http://www.jlr.org/content/33/11/1569.full.pdf+html" class="external autonumber external"></a>, 10. Endo A (1992). "The discovery and development of HMG-CoA reductase inhibitors" <i>Journal of Lipid Research</i> 33: 1569-1582</span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><a href="javascript:if(confirm('https://link.springer.com/content/pdf/10.2165%2F00003495-200666020-00002.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://link.springer.com/content/pdf/10.2165%2F00003495-200666020-00002.pdf'" tppabs="https://link.springer.com/content/pdf/10.2165%2F00003495-200666020-00002.pdf" class="external autonumber external"></a>, 11.	Laufs U, Custodis F, Böhm M (2006). "HMG-CoA Reductase Inhibitors in Chronic Heart Failure" <i>Drugs</i> 66: 145</span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text">Porter, K.E.; Turner, N.A.; Statins and myocardial remodeling: cell and molecular pathways; expert reviews in molecular medicine, 2011, 13 (22): pp.1-18</span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><a href="javascript:if(confirm('http://www.jlr.org/content/23/3/466.full.pdf+html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.jlr.org/content/23/3/466.full.pdf+html'" tppabs="http://www.jlr.org/content/23/3/466.full.pdf+html" class="external autonumber external"></a>, Miettinen TA (1982). "Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins" <i>The Journal of Lipid Research</i> 23: 466-473</span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><a href="javascript:if(confirm('http://dmd.aspetjournals.org/content/dmd/25/3/321.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://dmd.aspetjournals.org/content/dmd/25/3/321.full.pdf'" tppabs="http://dmd.aspetjournals.org/content/dmd/25/3/321.full.pdf" class="external autonumber external"></a>, Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, Ploschke J, Radtke M (1996). "Metabolism of cerivastatin by human liver microsomes in vitro". <i>Drug Metabolism and Dispersion</i>, 25 (3): 321-331</span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00439  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00439'" tppabs="https://www.drugbank.ca/drugs/DB00439" class="external text external">"Cerivastatin"</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFKalariaWassenaar2002" class="citation journal cs1">Kalaria D, Wassenaar W (2002). "Rhabdomyolysis and cerivastatin: Was it a problem of dose?". <i>CMAJ</i>. <b>167</b> (7): 737.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text">Moßhammer, D.; Schaeffeler, E.; Schwab, M.; Mörike, K.; Mechanisms and assessment of statin-related muscular adverse effects <i>British Journal of Clinical Pharmacology</i> 78(3), 2014, pp. 454–466</span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite id="CITEREFStaffaChangGreen2002" class="citation journal cs1">Staffa JA, Chang J, Green L (2002). "Cerivastatin and Reports of Fatal Rhabdomyolysis". <i>N Engl J Med</i>. <b>346</b>: 539–540. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2Fnejm200202143460721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2Fnejm200202143460721'" tppabs="https://doi.org/10.1056%2Fnejm200202143460721" class="external text external">10.1056/nejm200202143460721</a>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFKalariaWassenaar" class="citation journal cs1">Kalaria D, Wassenaar W. "Rhabdomyolysis and cerivastatin: Was it a problem of dose?". <i>CMAJ</i>. <b>167</b> (7): 737.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFFurbergPitt2001" class="citation journal cs1">Furberg CD, Pitt B (2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524" class="external text external">"Withdrawal of cerivastatin from the world market"</a>. <i>Curr Control Trials Cardiovasc Med</i>. <b>2</b> (5): 205–207. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1186%2Fcvm-2-5-205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fcvm-2-5-205'" tppabs="https://doi.org/10.1186%2Fcvm-2-5-205" class="external text external">10.1186/cvm-2-5-205</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59524" class="external text external">59524</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11806796  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11806796'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11806796" class="external text external">11806796</a>.</cite></span></li><li id="cite_note-Staffa_2002-22"> <span id="mw-reference-text-cite_note-Staffa_2002-22" class="mw-reference-text"><cite class="citation journal cs1">Staffa JA, Chang J, Green L (2002). "Cerivastatin and Reports of Fatal Rhabdomyolysis". <i>N Engl J Med</i>. <b>346</b>: 539–540. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2Fnejm200202143460721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2Fnejm200202143460721'" tppabs="https://doi.org/10.1056%2Fnejm200202143460721" class="external text external">10.1056/nejm200202143460721</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFBobergAngerbauerFeyKanhai1996" class="citation journal cs1">Boberg M, Angerbauer R, Fey P, Kanhai WK, Karl W, Kern A, Ploschke J, Radtke M (1996). "Metabolism of cerivastatin by human liver microsomes in vitro". <i>Drug Metabolism and Dispersion</i>. <b>25</b> (3): 321–331.</cite></span></li></ol></div></div>

<div role="navigation" class="navbox" aria-labelledby="Lipid-modifying_agents_(C10)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Lipid-modifying_agents_(C10)" style="font-size:114%;margin:0 4em">Lipid-modifying agents (C10)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">GI tract</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Cholesterol absorption inhibitors, NPC1L1</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Ezetimibe.htm" tppabs="https://ptable.com/wiki/compounds/A/Ezetimibe" title="Ezetimibe">Ezetimibe</a></li>
<li>SCH-48461</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Bile acid sequestrants/resins (LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Colesevelam.htm" tppabs="https://ptable.com/wiki/compounds/A/Colesevelam" title="Colesevelam">Colesevelam</a></li>
<li>Colestilan</li>
<li><a href="Colestipol.htm" tppabs="https://ptable.com/wiki/compounds/A/Colestipol" title="Colestipol">Colestipol</a></li>
<li>Colestyramine</li>
<li>Colextran</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Liver</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Statins (HMG-CoA reductase, LDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Atorvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Atorvastatin" title="Atorvastatin">Atorvastatin</a></li>
<li><a href="Cerivastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cerivastatin" title="Cerivastatin">Cerivastatin</a><sup>‡</sup></li>
<li><a href="Fluvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvastatin" title="Fluvastatin">Fluvastatin</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li><a href="Mevastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li>Pitavastatin</li>
<li><a href="Pravastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pravastatin" title="Pravastatin">Pravastatin</a></li>
<li><a href="Rosuvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosuvastatin" title="Rosuvastatin">Rosuvastatin</a></li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Niacin and derivatives (HDL and LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acipimox</li>
<li>Aluminium nicotinate</li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a></li>
<li>Niceritrol</li>
<li><a href="Nicofuranose.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicofuranose" title="Nicofuranose">Nicofuranose</a></li>
<li><a href="Nicotinyl_alcohol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinyl_alcohol" title="Nicotinyl alcohol">Nicotinyl alcohol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MTTP inhibitors (VLDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dirlotapide</li>
<li>Lomitapide</li>
<li>Mitratapide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">ATP citrate lyase inhibitors (LDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bempedoic acid</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Blood vessels</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Fibrates (PPAR)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aluminium clofibrate</li>
<li><a href="Bezafibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezafibrate" title="Bezafibrate">Bezafibrate</a></li>
<li><span class="new">Choline fenofibrate</span></li>
<li><a href="Ciprofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciprofibrate" title="Ciprofibrate">Ciprofibrate</a></li>
<li>Clinofibrate</li>
<li><a href="Clofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofibrate" title="Clofibrate">Clofibrate</a><sup>‡</sup></li>
<li>Clofibride</li>
<li>Etofibrate</li>
<li><a href="Fenofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenofibrate" title="Fenofibrate">Fenofibrate</a></li>
<li><a href="Gemfibrozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemfibrozil" title="Gemfibrozil">Gemfibrozil</a></li>
<li>Pemafibrate</li>
<li>Ronifibrate</li>
<li>Simfibrate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CETP inhibitors (HDL)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Anacetrapib<sup>†</sup></li>
<li>Dalcetrapib<sup>§</sup></li>
<li>Evacetrapib<sup>§</sup></li>
<li><span class="new">Obicetrapib</span><sup>†</sup></li>
<li>Torcetrapib<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">PCSK9 inhibitors (LDL)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alirocumab</li>
<li>Bococizumab</li>
<li>Evolocumab</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bempedoic acid/ezetimibe</li>
<li>Ezetimibe/atorvastatin</li>
<li>Ezetimibe/rosuvastatin</li>
<li>Ezetimibe/simvastatin</li>
<li>Fenofibrate/pravastatin</li>
<li>Fenofibrate/simvastatin</li>
<li>Niacin/laropiprant</li>
<li>Niacin/lovastatin</li>
<li>Niacin/simvastatin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alipogene tiparvovec</li>
<li>Azacosterol</li>
<li>Azalanstat</li>
<li>Benfluorex<sup>‡</sup></li>
<li>Darapladib<sup>§</sup></li>
<li><a href="Dextrothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dextrothyroxine" title="Dextrothyroxine">Dextrothyroxine</a><sup>‡</sup></li>
<li>Lapaquistat<sup>§</sup></li>
<li>Magnesium pyridoxal 5-phosphate glutamate</li>
<li><a href="Meglutol.htm" tppabs="https://ptable.com/wiki/compounds/A/Meglutol" title="Meglutol">Meglutol</a></li>
<li>Mipomersen</li>
<li>Omega-3-triglycerides</li>
<li>Policosanol</li>
<li><a href="Probucol.htm" tppabs="https://ptable.com/wiki/compounds/A/Probucol" title="Probucol">Probucol</a></li>
<li>Tiadenol</li>
<li>Triparanol<sup>‡</sup></li>
<li>Volanesorsen</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>









<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-10" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Cerivastatin&oldid=966965476  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Cerivastatin&oldid=966965476'" tppabs="https://en.wikipedia.org/wiki/?title=Cerivastatin&oldid=966965476">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>